fluconazole has been researched along with Communicable Diseases, Emerging in 6 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Communicable Diseases, Emerging: Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coccidioidomycosis is an insidious fungal disease, endemic to arid regions of the Americas, which is becoming more frequently recognised worldwide." | 1.40 | Beyond the superficial: Coccidioides immitis fungaemia in a man with fever, fatigue and skin nodules: a case of an emerging and evolving pathogen. ( Baxi, SM; Chin-Hong, P; Iribarne, D; Langelier, C, 2014) |
| "Mucormycosis was diagnosed in the neutropenic state following allogeneic hematopoietic cell transplantation (n=3) or intense chemotherapy (n=3)." | 1.33 | Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. ( Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G, 2005) |
| "The spectrum of candidiasis has changed with the emergence of non-albicans Candida spp." | 1.33 | Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. ( Aggarwal, P; Capoor, MR; Deb, M; Nair, D; Srivastava, L; Verma, PK, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrs, VR | 1 |
| van Doorn, TM | 1 |
| Houbraken, J | 1 |
| Kidd, SE | 1 |
| Martin, P | 1 |
| Pinheiro, MD | 1 |
| Richardson, M | 1 |
| Varga, J | 1 |
| Samson, RA | 1 |
| Langelier, C | 1 |
| Baxi, SM | 1 |
| Iribarne, D | 1 |
| Chin-Hong, P | 1 |
| Silva, V | 1 |
| Zepeda, G | 1 |
| Alvareda, D | 1 |
| Bethge, WA | 1 |
| Schmalzing, M | 1 |
| Stuhler, G | 1 |
| Schumacher, U | 1 |
| Kröber, SM | 1 |
| Horger, M | 1 |
| Einsele, H | 1 |
| Kanz, L | 1 |
| Hebart, H | 1 |
| Capoor, MR | 1 |
| Nair, D | 1 |
| Deb, M | 1 |
| Verma, PK | 1 |
| Srivastava, L | 1 |
| Aggarwal, P | 1 |
| Kratzer, C | 1 |
| Tobudic, S | 1 |
| Schmoll, M | 1 |
| Graninger, W | 1 |
| Georgopoulos, A | 1 |
6 other studies available for fluconazole and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs.
Topics: Air Microbiology; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cat Diseases; | 2013 |
Beyond the superficial: Coccidioides immitis fungaemia in a man with fever, fatigue and skin nodules: a case of an emerging and evolving pathogen.
Topics: Antifungal Agents; Coccidioidomycosis; Communicable Diseases, Emerging; Diagnosis, Differential; Fat | 2014 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Res | 2003 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emergi | 2005 |
Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Communicable Diseases, Emerging; Dru | 2005 |
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communica | 2006 |